Aldafermin
Based on 1 Customer Validation
Aldafermin (NGM282) is an analog of fibroblast growth factor 19. Aldafermin can be used for the research of nonalcoholic steatohepatitis (NASH).
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Reinheit : 97.63%
- CAS. Nr.: 1616639-03-2
- Molecular Weight:21.06 kDa
-
Speicherung:Shipping with dry ice
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Beschreibung
In Vitro
Aldafermin can inhibit bile acid synthesis and regulates metabolic homeostasis[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | 2011-05 | PHASE1 |
Anwendung
ELISA, FACS, Functional assay
Verified Bioactivity
-
Immobilized Aldafermin can bind Anti-FGF-19 Antibody. The EC50 for this effect is 1.41 ng/mL.
Product Details
-
CAS. Nr. 1616639-03-2
-
Synonyms NGM282
-
Molecular Weight 21.06 kDa
-
Conjugated
Unconjugated
-
Format
-
FGF19 (fibroblast growth factor 19)5-194
-
Product Properties
-
Appearance
Liquid
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Reinheit
97.63%
-
Reconstitution
The product can be reconstituted/diluted with sterile PBS or saline.
-
Storage & Stability
Please store the product under the recommended conditions in the Certificate of Analysis.
-
Versand
Shipping with dry ice.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)